Immunotoxin Therapy in Treating Patients With Malignant Glioma
Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Immunotoxins can locate tumor cells and kill them without harming normal cells.
This may be an effective treatment for malignant glioma.
PURPOSE: Phase I/II trial to study the effectiveness of immunotoxin therapy in treating
patients who have malignant glioma.